Agios Pharmaceuticals Profit Margin

Agios Pharmaceuticals (AGIO) currently reports a profit margin of -418.24% as of June 2026. That compares with 1590.42% in the prior-year period — down 126.3% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Agios Pharmaceuticals's profit margin history and peer comparisons.

Agios Pharmaceuticals's profit margin decreased from 1590.42% to -418.24% — a 126.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Agios Pharmaceuticals's profit margin of -418.24% is lower than the Healthcare sector average of 10.58%. That is roughly 4052.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Agios Pharmaceuticals's current -418.24% should be judged against Healthcare norms (sector average: 10.58%) and against AGIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -418.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Agios Pharmaceuticals, and consider following AGIO for alerts when major investors trade the stock.